Free Trial
NASDAQ:NATR

Nature's Sunshine Products (NATR) Stock Price, News & Analysis

Nature's Sunshine Products logo
$17.14 -0.20 (-1.15%)
Closing price 09/5/2025 04:00 PM Eastern
Extended Trading
$17.13 -0.01 (-0.06%)
As of 09/5/2025 04:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Nature's Sunshine Products Stock (NASDAQ:NATR)

Key Stats

Today's Range
$17.00
$17.58
50-Day Range
$14.01
$17.34
52-Week Range
$11.01
$18.06
Volume
82,208 shs
Average Volume
115,389 shs
Market Capitalization
$302.28 million
P/E Ratio
23.16
Dividend Yield
N/A
Price Target
$19.67
Consensus Rating
Buy

Company Overview

Nature's Sunshine Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
60th Percentile Overall Score

NATR MarketRank™: 

Nature's Sunshine Products scored higher than 60% of companies evaluated by MarketBeat, and ranked 497th out of 932 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Upside Potential

    Nature's Sunshine Products has a consensus price target of $19.67, representing about 14.7% upside from its current price of $17.14.

  • Amount of Analyst Coverage

    Nature's Sunshine Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nature's Sunshine Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nature's Sunshine Products is 23.16, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 277.94.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nature's Sunshine Products is 23.16, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 76.08.

  • Price to Book Value per Share Ratio

    Nature's Sunshine Products has a P/B Ratio of 1.97. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nature's Sunshine Products' valuation and earnings.
  • Percentage of Shares Shorted

    1.28% of the float of Nature's Sunshine Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Nature's Sunshine Products has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nature's Sunshine Products has recently increased by 7.30%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nature's Sunshine Products does not currently pay a dividend.

  • Dividend Growth

    Nature's Sunshine Products does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Nature's Sunshine Products is 54.05%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Read more about Nature's Sunshine Products' dividend.
  • Percentage of Shares Shorted

    1.28% of the float of Nature's Sunshine Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Nature's Sunshine Products has a short interest ratio ("days to cover") of 2.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nature's Sunshine Products has recently increased by 7.30%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nature's Sunshine Products has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 6 news articles for Nature's Sunshine Products this week, compared to 2 articles on an average week.
  • Search Interest

    2 people have searched for NATR on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Nature's Sunshine Products to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Nature's Sunshine Products insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $33,123,599.00 in company stock.

  • Percentage Held by Insiders

    Only 4.70% of the stock of Nature's Sunshine Products is held by insiders.

  • Percentage Held by Institutions

    79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Nature's Sunshine Products' insider trading history.
Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NATR Stock News Headlines

Stunning new initiative unfolding in the White House?
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
Nature's Sunshine: Premium Valuation Without Moats, Sell
See More Headlines

NATR Stock Analysis - Frequently Asked Questions

Nature's Sunshine Products' stock was trading at $14.66 at the beginning of 2025. Since then, NATR stock has increased by 16.9% and is now trading at $17.14.

Nature's Sunshine Products, Inc. (NASDAQ:NATR) released its quarterly earnings results on Thursday, July, 31st. The company reported $0.35 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.17 by $0.19. The company had revenue of $114.75 million for the quarter, compared to analyst estimates of $113.10 million. Nature's Sunshine Products had a trailing twelve-month return on equity of 10.19% and a net margin of 3.06%.
Read the conference call transcript
.

Top institutional investors of Nature's Sunshine Products include Kennedy Capital Management LLC (3.34%), Acadian Asset Management LLC (3.16%), Paradigm Capital Management Inc. NY (2.18%) and AWM Investment Company Inc. (1.98%). Insiders that own company stock include Wynnefield Partners Small Cap, Bryant J Yates, Daniel C Norman, Jonathan David Lanoy, Nathan G Brower and Fosun Pharmaceutical Shanghai.
View institutional ownership trends
.

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nature's Sunshine Products investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL), Meta Platforms (META) and Disc Medicine (IRON).

Company Calendar

Last Earnings
7/31/2025
Today
9/06/2025
Next Earnings (Estimated)
11/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Personal Products
Current Symbol
NASDAQ:NATR
CIK
275053
Employees
850
Year Founded
N/A

Price Target and Rating

High Price Target
$22.00
Low Price Target
$18.00
Potential Upside/Downside
+14.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
$0.74
Trailing P/E Ratio
23.16
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.70 million
Net Margins
3.06%
Pretax Margin
5.21%
Return on Equity
10.19%
Return on Assets
6.71%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.27
Quick Ratio
1.35

Sales & Book Value

Annual Sales
$460.82 million
Price / Sales
0.66
Cash Flow
$1.23 per share
Price / Cash Flow
13.88
Book Value
$8.71 per share
Price / Book
1.97

Miscellaneous

Outstanding Shares
17,636,000
Free Float
16,807,000
Market Cap
$302.28 million
Optionable
Optionable
Beta
1.11
7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (NASDAQ:NATR) was last updated on 9/6/2025 by MarketBeat.com Staff
From Our Partners